US Stocks
US Options
Emerging Asia
GBP Cash Savings
Charts & Tools
Paper Trading
Extended Hours
Overview
Desktop
Wall Street JournalE
EVOK
Evoke Pharma Inc
3.87
-0.03-0.77%After Hours: 3.890 +0.020 +0.52%16:00 09/06 EDT
OPEN/PREV CLOSE4.090/3.900
TODAY RANGE3.750-4.090
VOL18.85K
MARKET CAP3.17M
52 WEEK RANGE3.540-18.60
AVG VOL (3M)61.41K
% TURNOVER2.30%
TURNOVER--
P/E (TTM)-0.2384
% RANGE8.72%
EPS(TTM)-16.2313
P/E(FORWARD)-4.0313
P/B1.067
BVPS3.627
DIVIDEND--
P/S0.2081
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.73M
SHARES OUTSTANDING819.27K
NEXT EARNINGS11/07-11/11
FREE FLOAT705.27K
LOT SIZE1
EX-DIV DATE08/01/2024
News
Press Releases
Financial Reports
Profile
Seeking Alpha·08/29 20:34
Evoke Pharma files for $50M mixed securities shelf
Reuters·08/29 20:17
EVOKE PHARMA INC FILES FOR MIXED SHELF OF UP TO $50 MLN - SEC FILING
Reuters·08/23 07:50
BUZZ-Bookmaker Evoke's shares up on acquisition of Romania-based Winner.ro
Reuters·08/20 18:13
BUZZ-U.S. STOCKS ON THE MOVE-Medtronic, Texas Instruments, Fabrinet
Reuters·08/15 04:58
UK Stocks-Factors to watch on Aug 15
Seeking Alpha·08/13 21:48
Evoke Pharma files for mixed shelf offering
Investorplace·08/13 17:53
EVOK Stock Earnings: Evoke Pharma Misses EPS, Misses Revenue for Q2 2024
Press release·08/13 14:29
Evoke Pharma, Inc. Reports Financial Results for the Quarter Ended June 30, 2024
Seeking Alpha·08/13 13:05
Evoke Pharma GAAP EPS of -$0.93, revenue of $2.55M
Dow Jones·08/13 12:04
*Evoke Pharma Cuts FY24 View To Sales $11M-$12M >EVOK
Dow Jones·08/13 12:03
*Evoke Pharma 2Q Sales $2.55M >EVOK
Dow Jones·08/13 12:02
*Evoke Pharma 2Q Loss $1.27M >EVOK
Reuters·08/13 12:00
EVOKE PHARMA INC: REVISING ITS 2024 GUIDANCE TO A RANGE OF $11MLN - 12 MLN
Reuters·08/13 12:00
EVOKE PHARMA, INC. REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS
Same Industry
Name/Symbol
Change%
Price